Literature DB >> 6201362

A V region determinant (idiotope) expressed at high frequency in B lymphocytes is encoded by a large set of antibody structural genes.

R Dildrop, J Bovens, M Siekevitz, K Beyreuther, K Rajewsky.   

Abstract

Idiotope Ac38, a V region determinant of the lambda 1 chain-bearing, germ line encoded antibody B1-8, is expressed at high frequency (approximately 1/40) in lambda 1 chain-bearing B cells. Here, we describe the isolation of lambda-positive hybridomas from C57BL/6 mice which had been immunized with antibody Ac38, the antibody recognizing idiotope Ac38. In Northern blot analysis, mRNA isolated from 10 such hybridomas hybridizes with a cDNA probe from the VH gene expressed in the cell line B1-8. Amino acid sequence analysis of the VH regions of four of the hybridoma proteins reveals that they are all derived from related, though distinct, germ line VH genes. In one case the sequence data suggest that extensive somatic mutation has taken place. Only one of the four sequences derives from the same VH gene that is expressed in the cell line B1-8. Together with earlier evidence, the present data demonstrate that the Ac38 idiotope is a marker for at least five VH and three D region genes in the C57BL/6 germ line. This explains the high frequency at which this idiotope is expressed in the B cell population. In addition, our sequence determinations identify two VH genes in the C57BL/6 strain which are closely related (and possibly allelic) to two known BALB/c VH genes. One of these genes is the gene expressed in the BALB/c myeloma MOPC 104E.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201362      PMCID: PMC557380          DOI: 10.1002/j.1460-2075.1984.tb01840.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response.

Authors:  M Reth; G J Hämmerling; K Rajewsky
Journal:  Eur J Immunol       Date:  1978-06       Impact factor: 5.532

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Strain differences in the fine specificity of mouse anti-hapten antibodies.

Authors:  T Imanishi; O Mäkelä
Journal:  Eur J Immunol       Date:  1973-06       Impact factor: 5.532

5.  Analysis of the repertoire of anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in C 57 BL/6 mice by cell fusion. II. Characterization of idiotopes by monoclonal anti-idiotope antibodies.

Authors:  M Reth; T Imanishi-Kari; K Rajewsky
Journal:  Eur J Immunol       Date:  1979-12       Impact factor: 5.532

6.  Amino acid sequence of homogeneous antibodies to dextran and DNA rearrangements in heavy chain V-region gene segments.

Authors:  J Schilling; B Clevinger; J M Davie; L Hood
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

7.  Genetic control of antibody variable regions.

Authors:  M Weigert; R Riblet
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

8.  Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse.

Authors:  H Lemke; G J Hammerling; C Hohmann; K Rajewsky
Journal:  Nature       Date:  1978-01-19       Impact factor: 49.962

9.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Amino acid sequence of a mouse immunoglobulin mu chain.

Authors:  M Kehry; C Sibley; J Fuhrman; J Schilling; L E Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

View more
  8 in total

1.  Stepwise intraclonal maturation of antibody affinity through somatic hypermutation.

Authors:  C Kocks; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  Gene repertoire of the anti-poly(Glu60Ala30Tyr10) (GAT) immune response: comparison of VH, V kappa, and D regions used by anti-GAT antibodies and monoclonal antibodies produced after anti-idiotypic immunization.

Authors:  C Roth; J Rocca-Serra; G Sommé; M Fougereau; J Théze
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

3.  The idiotypic network and the internal image: possible regulation of a germ-line network by paucigene encoded Ab2 (anti-idiotypic) antibodies in the GAT system.

Authors:  P Ollier; J Rocca-Serra; G Sommé; J Thèze; M Fougereau
Journal:  EMBO J       Date:  1985-12-30       Impact factor: 11.598

4.  Molecular basis of an isogeneic anti-idiotypic response.

Authors:  F Sablitzky; K Rajewsky
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

5.  Somatic mutation and clonal expansion of B cells in an antigen-driven immune response.

Authors:  F Sablitzky; G Wildner; K Rajewsky
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

6.  Genetic basis for expression of the idiotypic network. One unique Ig VH germline gene accounts for the major family of Ab1 and Ab3 (Ab1') antibodies of the GAT system.

Authors:  C Schiff; M Milili; I Hue; S Rudikoff; M Fougereau
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

7.  Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment.

Authors:  I Förster; H Gu; K Rajewsky
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

8.  Most peripheral B cells in mice are ligand selected.

Authors:  H Gu; D Tarlinton; W Müller; K Rajewsky; I Förster
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.